Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Journal of Pharmacy Practice
|
April 13, 2016
Dosing Practices of Intravenous Acyclovir for Herpes Encephalitis in Obesity: Results of a Pharmacist Survey
Adrian Wong, Aaron J Pickering, Brian A Potoski
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
July 19, 2021
Open-source institutional guideline recommendations during the COVID-19 pandemic
Curtis D Collins, Jean Huang, Brian A Potoski
Open Forum Infectious Diseases
|
October 30, 2019
Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data
Cornelius J Clancy, Brian A Potoski, Deanna Buehrle, et al.
Pharmacotherapy
|
December 1, 2010
Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis
Kathleen R Sheridan, Brian A Potoski, Ryan K Shields, et al.
Infection Control and Hospital Epidemiology
|
November 13, 2007
Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus
Jason M Pogue, David L Paterson, A William Pasculle, et al.
Diagnostic Microbiology and Infectious Disease
|
March 26, 2019
Antimicrobial treatment challenges in the era of carbapenem resistance
Anna Maria Peri, Yohei Doi, Brian A Potoski, et al.
International Journal of Antimicrobial Agents
|
August 21, 2007
Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Sunil Bhat, Shigeki Fujitani, Brian A Potoski, et al.
Open Forum Infectious Diseases
|
August 21, 2023
Impact of Rapid Identification and Stewardship Intervention on Coagulase-Negative <i>Staphylococcus</i> Bloodstream Infection
Eli S Goshorn, J Alex Viehman, J Ryan Bariola, et al.
Antimicrobial Agents and Chemotherapy
|
November 9, 2016
Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure
Deanna J Buehrle, Ryan K Shields, Lloyd G Clarke, et al.
Pharmacotherapy
|
June 30, 2004
Meropenem administered as a prolonged infusion to treat serious gram-negative central nervous system infections
Blair Capitano, David P Nicolau, Brian A Potoski, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Journal of Pharmacy Practice
|
April 13, 2016
Dosing Practices of Intravenous Acyclovir for Herpes Encephalitis in Obesity: Results of a Pharmacist Survey
Adrian Wong, Aaron J Pickering, Brian A Potoski
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
July 19, 2021
Open-source institutional guideline recommendations during the COVID-19 pandemic
Curtis D Collins, Jean Huang, Brian A Potoski
Open Forum Infectious Diseases
|
October 30, 2019
Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data
Cornelius J Clancy, Brian A Potoski, Deanna Buehrle, et al.
Pharmacotherapy
|
December 1, 2010
Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis
Kathleen R Sheridan, Brian A Potoski, Ryan K Shields, et al.
Infection Control and Hospital Epidemiology
|
November 13, 2007
Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus
Jason M Pogue, David L Paterson, A William Pasculle, et al.
Diagnostic Microbiology and Infectious Disease
|
March 26, 2019
Antimicrobial treatment challenges in the era of carbapenem resistance
Anna Maria Peri, Yohei Doi, Brian A Potoski, et al.
International Journal of Antimicrobial Agents
|
August 21, 2007
Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Sunil Bhat, Shigeki Fujitani, Brian A Potoski, et al.
Open Forum Infectious Diseases
|
August 21, 2023
Impact of Rapid Identification and Stewardship Intervention on Coagulase-Negative <i>Staphylococcus</i> Bloodstream Infection
Eli S Goshorn, J Alex Viehman, J Ryan Bariola, et al.
Antimicrobial Agents and Chemotherapy
|
November 9, 2016
Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure
Deanna J Buehrle, Ryan K Shields, Lloyd G Clarke, et al.
Pharmacotherapy
|
June 30, 2004
Meropenem administered as a prolonged infusion to treat serious gram-negative central nervous system infections
Blair Capitano, David P Nicolau, Brian A Potoski, et al.
Page
of 5